Advertisement

Topics

Vemurafenib for high risk melanoma patients

04:55 EDT 11 Sep 2017 | ecancermedicalscience

Dr Lewis presents in a press conference at the ESMO 2017 Congress in Madrid data from a randomised, double-blind, placebo-controlled study of adjuvant vemurafenib in patients with completely resected, BRAFV600 melanoma at high risk for recurrence. Dr...

Original Article: Vemurafenib for high risk melanoma patients

NEXT ARTICLE

More From BioPortfolio on "Vemurafenib for high risk melanoma patients"

Quick Search
Advertisement
 

Relevant Topic

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...